Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 44, 2014 - Issue 4
647
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6

, , , , &
Pages 309-319 | Received 11 Jul 2013, Accepted 14 Aug 2013, Published online: 06 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Iram Kaukab, Syed Nisar Hussain Shah, Zelal Jaber Kharaba, Manal Ali Buabeid, Yaseen Abd Alfoteih & Ghulam Murtaza. (2020) Effect of clarithromycin pre-treatment on the pharmacokinetics of metoclopramide after their simultaneous oral intake. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 735-740.
Read now
Marike Visser, Matthew J. Zaya, Charles W. Locuson, Dawn M. Boothe & Dawn A. Merritt. (2019) Comparison of predicted intrinsic hepatic clearance of 30 pharmaceuticals in canine and feline liver microsomes. Xenobiotica 49:2, pages 177-186.
Read now
Petra Matalová, Karel Urbánek & Pavel Anzenbacher. (2016) Specific features of pharmacokinetics in children. Drug Metabolism Reviews 48:1, pages 70-79.
Read now

Articles from other publishers (30)

Angela Wu, Helen Anderson, Curtis Hughesman, Sean Young, Caroline Lohrisch, Colin J. D. Ross & Bruce C. Carleton. (2023) Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. Frontiers in Pharmacology 14.
Crossref
Franz-Martin Fink, Marta Bognar, Petra Hengl, Markus Paulmichl & Charity Nofziger. (2023) Case report: metoclopramide induced acute dystonic reaction in adolescent CYP2D6 poor metabolizers. Frontiers in Pharmacology 14.
Crossref
Solène Marie, Kayla L. Frost, Raymond K. Hau, Lucy Martinez-Guerrero, Jailyn M. Izu, Cassandra M. Myers, Stephen H. Wright & Nathan J. Cherrington. (2023) Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients. Acta Pharmaceutica Sinica B 13:1, pages 1-28.
Crossref
Dalia Safaa Hamdi & Masar Basim Mohsin Mohamed. (2022) Formulation of metoclopramide HCl gastroretentive film and in vitro- in silico prediction using Gastroplus® PBPK software. Saudi Pharmaceutical Journal 30:12, pages 1816-1824.
Crossref
Louise Breuil, Nora Ziani, Sarah Leterrier, Gaëlle Hugon, Fabien Caillé, Viviane Bouilleret, Charles Truillet, Maud Goislard, Myriam El Biali, Martin Bauer, Oliver Langer, Sébastien Goutal & Nicolas Tournier. (2022) Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [11C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier. Pharmaceutics 14:12, pages 2650.
Crossref
Ali Alipour Najmi, Rainer Bischoff & Hjalmar P. Permentier. (2022) N-Dealkylation of Amines. Molecules 27:10, pages 3293.
Crossref
Eleni Karatza, Samit Ganguly, Chi D. Hornik, William J. Muller, Amira Al-Uzri, Laura James, Stephen J. Balevic & Daniel Gonzalez. (2022) External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data. Frontiers in Pharmacology 13.
Crossref
Arnt Schellekens, Kees Kramers, Thomas Knuijver, Maarten Belgers, Rogier Donders & Robbert‐Jan Verkes. (2021) Response to Luz & Mash on cardiac toxicity of ibogaine. Addiction 117:3, pages 837-838.
Crossref
Matthias Luz & Deborah C. Mash. (2021) Reply to Knuijver et al . on the ‘Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study’ . Addiction 117:3, pages 835-836.
Crossref
Mohamed Sheikh Hassan & Mosab Ahmed Nor. (2022) Metoclopramide induced acute dystonic reaction: A case report. Annals of Medicine and Surgery 74, pages 103248.
Crossref
Thomas Knuijver, Arnt Schellekens, Maarten Belgers, Rogier Donders, Toon van Oosteren, Kees Kramers & Robbert Verkes. (2021) Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study. Addiction 117:1, pages 118-128.
Crossref
Joshua Radke, Kelly Tocki & Brett A. Faine. (2022) A Review of the Metabolism and Potential Drug-drug Interactions With Addictive Drugs. Journal of Addiction Medicine 16:1, pages e30-e39.
Crossref
David Moreno Ajona, María Dolores Villar Martínez, Calvin Chan & Peter J. Goadsby. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 548 589 .
Jiawei Guo, Fengwei Li, Fangyuan Cheng, Li Ma, Xiaohui Liu, Pradeepraj Durairaj, Gang Zhang, Dandan Tang, Xiangtian Long, Wei Zhang, Lei Du, Xingwang Zhang & Shengying Li. (2021) Bacterial Biosynthetic P450 Enzyme PikC D50N : A Potential Biocatalyst for the Preparation of Human Drug Metabolites . The Journal of Organic Chemistry 86:21, pages 14563-14571.
Crossref
Holger Petri. (2021) Arzneimitteltherapiesicherheit: Interaktionspotenzial der Antiemetika. Deutsches Ärzteblatt Online.
Crossref
Irene Hernández-Lozano, Severin Mairinger, Michael Sauberer, Johann Stanek, Thomas Filip, Thomas Wanek, Giuliano Ciarimboli, Nicolas Tournier & Oliver Langer. (2021) Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [11C]Metoclopramide in Mice. Pharmaceutical Research 38:1, pages 127-140.
Crossref
Cecilia Nwadiuto Amadi & Wisdom Izuchukwu Nwachukwu. (2020) The effects of oral administration of Cola nitida on the pharmacokinetic profile of metoclopramide in rabbits. BMC Pharmacology and Toxicology 21:1.
Crossref
Jung-Woo Bae, Kyung-Yul Oh, So-Jung Yoon, Hyo-Bin Shin, Eui Hyun Jung, Chang-Keun Cho, Chang Woo Lim, Pureum Kang, Chang-Ik Choi, Choon-Gon Jang, Seok-Yong Lee & Yun Jeong Lee. (2020) Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide. Archives of Pharmacal Research 43:11, pages 1207-1213.
Crossref
Iram Kaukab, Syed Nisar Hussain Shah, Zelal Kharaba, Ghulam Murtaza, Abubaker Ali Saad & Shakeel Ahmad. (2019) Evaluation of Pharmacokinetic Interaction of Cilostazol with Metoclopramide after Oral Administration in Human. Current Drug Metabolism 20:11, pages 924-928.
Crossref
Iram Kaukab, Syed Nisar Hussain Shah & Ghulam Murtaza. (2019) Single Dose Pharmacokinetics of Metoclopramide Oral Tablets Utilizing HPLC-UV Method. Current Pharmaceutical Analysis 15:7, pages 703-709.
Crossref
Eng Wee Chua, Simon P. Harger & Martin A. Kennedy. (2019) Metoclopramide-Induced Acute Dystonic Reactions May Be Associated With the CYP2D6 Poor Metabolizer Status and Pregnancy-Related Hormonal Changes. Frontiers in Pharmacology 10.
Crossref
Sarah M. Glass, Sabrina M. Leddy, Michael C. Orwin, Garret P. Miller, Kyle A. Furge & Laura Lowe Furge. (2019) Rolapitant Is a Reversible Inhibitor of CYP2D6. Drug Metabolism and Disposition 47:6, pages 567-573.
Crossref
Peter H. Hinderling & Yichao Yu. (2018) Quantitative Assessment of the Effect of Chronic Kidney Disease on the Nonrenal Clearance of 10 Drugs After Intravenous Administration. Clinical Pharmacology in Drug Development 8:2, pages 138-151.
Crossref
Mellar P. Davis, Renee Weller & Sally Regel. 2019. Textbook of Palliative Care. Textbook of Palliative Care 259 273 .
Jelle Reinen, Martijn Smit & Mira Wenker. (2018) Evaluation of Strategies for the Assessment of Drug–Drug Interactions Involving Cytochrome P450 Enzymes. European Journal of Drug Metabolism and Pharmacokinetics 43:6, pages 737-750.
Crossref
Fabien Caillé, Sébastien Goutal, Solène Marie, Sylvain Auvity, Salvatore Cisternino, Bertrand Kuhnast, Géraldine Pottier & Nicolas Tournier. (2018) Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide. Contrast Media & Molecular Imaging 2018, pages 1-8.
Crossref
Mellar P. Davis, Renee Weller & Sally Regel. 2018. Textbook of Palliative Care. Textbook of Palliative Care 1 15 .
Katja Susanne Just, Katharina Luise Schneider, Marlen Schurig, Julia Carolin Stingl & Jürgen Brockmöller. (2017) Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics. Pharmacogenomics 18:13, pages 1281-1297.
Crossref
F. Peter Guengerich. 2015. Cytochrome P450. Cytochrome P450 523 785 .
Amanda K. Bolles, Rina Fujiwara, Erran D. Briggs, Amin A. Nomeir & Laura Lowe Furge. (2014) Mechanism-Based Inactivation of Human Cytochrome P450 3A4 by Two Piperazine-Containing Compounds. Drug Metabolism and Disposition 42:12, pages 2087-2096.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.